Asymmetric phenotype associated with rare myelin protein zero mutation

Journal of Clinical Neuromuscular Disease

Volumn 11, Issue 3, 2010, Pages 110-113

  Souayah, Nizar ^a   Tick Chong, Peter Siao ^b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Charcot Marie Tooth; Demyelinating; Hereditary; Mutation; Myelin protein zero; Neuropathy

Indexed keywords

MYELIN PROTEIN; MYELIN PROTEIN ZERO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; GENE MUTATION; HUMAN; MALE; MOTOR NERVE CONDUCTION; MUSCLE INNERVATION; MUSCLE WEAKNESS; NEUROLOGIC EXAMINATION; PERONEUS MUSCLE; PHENOTYPE; PRIORITY JOURNAL;

ADULT; AGED; ARGININE; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; CHILD, PRESCHOOL; ELECTROMYOGRAPHY; FAMILY HEALTH; FOOT DEFORMITIES; FUNCTIONAL LATERALITY; HISTIDINE; HUMANS; MALE; MUSCLE, SKELETAL; MUTATION; MYELIN P0 PROTEIN; NEURAL CONDUCTION; NEUROMUSCULAR DISEASES; PHENOTYPE;

EID: 77949469108     PISSN: 15220443     EISSN: 15371611     Source Type: Journal    
DOI: 10.1097/CND.0b013e3181c5058a     Document Type: Article

References (15)

1. Giese KP, Martini R, Lemke G, et al. Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell. 1992;71:565-576.
2. Xu W, Shy M, Kamholz J, et al. Mutations in the cytoplasmic domain of P0 reveal a role for PKCmediated phosphorylation in adhesion and myelination. J Cell Biol. 2001;155:439-446.
3. Souayah N, Seltzer WK, Brannagan TH, et al. Rare myelin protein zero sequence variant in late onset CMT1B. J Neurol Sci. 2007;263:177-179.
4. Shy ME, Jani A, Krajewski K, et al. Phenotypic clustering in MPZ mutations. Brain. 2004;127:371-384.
5. Shy ME. Peripheral neuropathies caused by mutations in the myelin protein zero. J Neurol Sci. 2006;242:55-66.
6. Greenfield S, Brostoff S, Eylar EH, et al. Protein composition of myelin of the peripheral nervous system. J Neurochem. 1973;20:1207-1216.
7. Eylar EH, Uyemura K, Brostoff SW, et al. Proposed nomenclature for PNS myelin proteins. Neurochem Res. 1979;4:289-293.
8. Watanabe M, Yamamoto N, Ohkoshi N, et al. Corticosteroid- responsive asymmetric neuropathy with a myelin protein zero gene mutation. Neurology. 2002;59:767-769.
9. Rouger H, LeGuern E, Gouider R, et al. High frequency of mutations in codon 98 of the peripheral myelin protein P0 gene in 20 French CMT1 patients. Am J Hum Genet. 1996;58:638-641.
10. Ohnishi A, Ohnari K, Hashimoto T, et al. A family of hereditary motor and sensory neuropathy type I with a new type of myelin P0 mutation. Rinsho Shinkeigaku. 1994;34:546-551.
11. Lagueny A, Latour P, Vital A, et al. Mild recurrent neuropathy in CMT1B with a novel nonsense mutation in the extracellular domain of the MPZ gene. J Neurol Neurosurg Psychiatry. 2001;70:232-235.
12. Hayasaka K, Ohnishi A, Takada G, et al. Mutation of the myelin P0 gene in Charcot-Marie-tooth neuropathy type 1. Biochem Biophys Res Commun. 1993; 194:1317-1322.
13. Hayasaka K, Takada G, Ionasescu VV. Mutation of the myelin P0 gene in Charcot-Marie-Tooth neuropathy type 1B. Hum Mol Genet. 1993;2:1369-1372.
14. Bai Y, Ianokova E, Pu Q, et al. Effect of an R69C mutation in the myelin protein zero gene on myelination and ion channel subtypes. Arch Neurol. 2006;63:1787-1794.
15. Gabreels-Festen AA, Hoogendijk JE, Meijerink PH, et al. Two divergent types of nerve pathology in patients with different P0 mutations in Charcot-- Marie-Tooth disease. Neurology. 1996;47:761-765.